Figures & data
Table 1 Baseline patient characteristics
Table 2 Changes in clinical symptoms, social adjustment, and parents’ mental health status for patients with ADHD during the 8-week treatment with osmotic controlled-release formulation of methylphenidate
Table 3 Factors associated with changes in ADHD symptoms, social function, and mothers’ mental health status in patients with ADHD after switching from immediate-release to osmotic controlled-release formulation of methylphenidate
Table S1 Number of available assessments at each visit